Loading...

Cytokinetics, Incorporated

CYTKNASDAQ
Healthcare
Biotechnology
$34.36
$0.72(2.14%)

Cytokinetics, Incorporated (CYTK) Financial Performance & Statements

Review Cytokinetics, Incorporated’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.

Revenue Growth
145.34%
145.34%
Operating Income Growth
-8.07%
8.07%
Net Income Growth
-12.03%
12.03%
Operating Cash Flow Growth
4.45%
4.45%
Operating Margin
-2943.30%
2943.30%
Gross Margin
-1359.51%
1359.51%
Net Profit Margin
-3201.47%
3201.47%
ROE
801.26%
801.26%
ROIC
-51.22%
51.22%

Cytokinetics, Incorporated (CYTK) Financial Statements

Explore quarterly and annual reports including balance sheet, income statement, cash flow for Cytokinetics, Incorporated stock.

MetricQ4 2024Q3 2024Q2 2024Q1 2024
Revenue$16.93M$463000.00$249000.00$835000.00
Cost of Revenue$93.63M$84.61M$2.41M$2.33M
Gross Profit-$76.70M-$84.15M-$2.16M-$1.50M
Gross Profit Ratio-$4.53-$181.75-$8.66-$1.79
R&D Expenses$0.00$463000.00$77.19M$79.24M
SG&A Expenses$62.34M$56.65M$50.82M$45.50M
Operating Expenses$62.34M$141.26M$128.01M$124.74M
Total Costs & Expenses$155.97M$141.26M$130.42M$127.07M
Interest Income$15.01M$17.05M$11.55M$7.91M
Interest Expense$22.59M$22.30M$24.30M$17.32M
Depreciation & Amortization$2.38M$2.41M$2.41M$2.33M
EBITDA-$125.04M-$138.25M-$116.61M-$115.99M
EBITDA Ratio-$7.39-$298.59-$468.33-$138.91
Operating Income-$139.04M-$140.80M-$130.17M-$126.23M
Operating Income Ratio-$8.21-$304.11-$522.78-$151.18
Other Income/Expenses (Net)-$10.98M-$19.74M-$13.15M-$9.41M
Income Before Tax-$150.02M-$160.54M-$143.32M-$135.64M
Income Before Tax Ratio-$8.86-$346.75-$575.57-$162.45
Income Tax Expense$0.00$0.00$0.00$2.29M
Net Income-$150.02M-$160.54M-$143.32M-$135.64M
Net Income Ratio-$8.86-$346.75-$575.57-$162.45
EPS-$1.26-$1.36-$1.31-$1.33
Diluted EPS-$1.26-$1.36-$1.31-$1.33
Weighted Avg Shares Outstanding$118.08M$117.69M$109.24M$101.92M
Weighted Avg Shares Outstanding (Diluted)$118.08M$117.69M$109.24M$101.92M

Unlock 25+ Years of Financial Data

Get access to extended historical data, advanced metrics, and more with our premium plan

Frequently Asked Questions

;